AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 273: G559-G563, 1997;
0193-1857/97 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chance, W. T.
Right arrow Articles by Balasubramaniam, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chance, W. T.
Right arrow Articles by Balasubramaniam, A.

AJP - Gastrointestinal and Liver Physiology, Vol 273, Issue 2 559-G563, Copyright © 1997 by American Physiological Society


ARTICLES

Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-2

W. T. Chance, T. Foley-Nelson, I. Thomas and A. Balasubramaniam
Medical Research Service, Department of Veterans Affairs, Cincinnati, Ohio, USA.

Maintaining rats on total parenteral nutrition (TPN) for 6 days significantly reduced mass (-34%), protein (-32%), and DNA (-35%) in small intestine and colon (29-37% decrease). Coinfusion of glucagon-like peptide-2 (GLP-2) normalized each of these variables in duodenum, jejunum, and ileum, but not in colon. Histological analysis of tissue revealed normal mucosa thickness and villus height in small intestine of GLP-2-treated rats, whereas nontreated rats maintained on TPN exhibited villus shortening (-30%) and thinning (-23%) of mucosa. These results suggest that hormonal alterations may be more important than an absence of luminal nutrition in TPN-associated mucosal changes. Additionally, GLP-2 normalization of gut mucosa permits accurate assessment of the influence of reversal of hypoplasia on gut barrier function.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. W. Nelson, S. G. Murali, X. Liu, M. C. Koopmann, J. J. Holst, and D. M. Ney
Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1175 - R1184.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. D. Baumler, D. W. Nelson, D. M. Ney, and G. E. Groblewski
Loss of exocrine pancreatic stimulation during parenteral feeding suppresses digestive enzyme expression and induces Hsp70 expression
Am J Physiol Gastrointest Liver Physiol, March 1, 2007; 292(3): G857 - G866.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Stephens, B. Stoll, J. Cottrell, X. Chang, M. Helmrath, and D. G. Burrin
Glucagon-like peptide-2 acutely increases proximal small intestinal blood flow in TPN-fed neonatal piglets
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2006; 290(2): R283 - R289.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
G. R. Martin, L. E. Wallace, and D. L. Sigalet
Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome
Am J Physiol Gastrointest Liver Physiol, June 1, 2004; 286(6): G964 - G972.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. L. Cameron, P.-C. Yang, and M. H. Perdue
Glucagon-like peptide-2-enhanced barrier function reduces pathophysiology in a model of food allergy
Am J Physiol Gastrointest Liver Physiol, June 1, 2003; 284(6): G905 - G912.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
E. M. Dahly, M. B. Gillingham, Z. Guo, S. G. Murali, D. W. Nelson, J. J. Holst, and D. M. Ney
Role of luminal nutrients and endogenous GLP-2 in intestinal adaptation to mid-small bowel resection
Am J Physiol Gastrointest Liver Physiol, April 1, 2003; 284(4): G670 - G682.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
K. E. Mayo, L. J. Miller, D. Bataille, S. Dalle, B. Goke, B. Thorens, and D. J. Drucker
International Union of Pharmacology. XXXV. The Glucagon Receptor Family
Pharmacol. Rev., March 1, 2003; 55(1): 167 - 194.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
E. M. Dahly, Z. Guo, and D. M. Ney
Alterations in Enterocyte Proliferation and Apoptosis Accompany TPN-Induced Mucosal Hypoplasia and IGF-I-Induced Hyperplasia in Rats
J. Nutr., July 1, 2002; 132(7): 2010 - 2014.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
D J Drucker
Gut adaptation and the glucagon-like peptides
Gut, March 1, 2002; 50(3): 428 - 435.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Nian, J. Gu, D. M. Irwin, and D. J. Drucker
Human glucagon gene promoter sequences regulating tissue-specific versus nutrient-regulated gene expression
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R173 - R183.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. G. Burrin, Y. Petersen, B. Stoll, and P. Sangild
Glucagon-Like Peptide 2: A Nutrient-Responsive Gut Growth Factor
J. Nutr., March 1, 2001; 131(3): 709 - 712.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. M. Secor, E. E. Whang, J. S. Lane, S. W. Ashley, and J. Diamond
Luminal and systemic signals trigger intestinal adaptation in the juvenile python
Am J Physiol Gastrointest Liver Physiol, December 1, 2000; 279(6): G1177 - G1187.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. G. Burrin, B. Stoll, R. Jiang, Y. Petersen, J. Elnif, R. K. Buddington, M. Schmidt, J. J. Holst, B. Hartmann, and P. T. Sangild
GLP-2 stimulates intestinal growth in premature TPN-fed pigs by suppressing proteolysis and apoptosis
Am J Physiol Gastrointest Liver Physiol, December 1, 2000; 279(6): G1249 - G1256.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M A Benjamin, D M McKay, P-C Yang, H Cameron, and M H Perdue
Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse
Gut, July 1, 2000; 47(1): 112 - 119.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. B. Gillingham, E. M. Dahly, H. V. Carey, M. D. Clark, K. R. Kritsch, and D. M. Ney
Differential jejunal and colonic adaptation due to resection and IGF-I in parenterally fed rats
Am J Physiol Gastrointest Liver Physiol, May 1, 2000; 278(5): G700 - G709.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
P. A. Kitchen, A. J. Fitzgerald, R. A. Goodlad, N. F. Barley, M. A. Ghatei, S. Legon, S. R. Bloom, A. Price, J. R. F. Walters, and A. Forbes
Glucagon-like peptide-2 increases sucrase-isomaltase but not caudal-related homeobox protein-2 gene expression
Am J Physiol Gastrointest Liver Physiol, March 1, 2000; 278(3): G425 - G428.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
J Thulesen, B Hartmann, C Nielsen, J J Holst, and S S Poulsen
Diabetic intestinal growth adaptation and glucagon-like peptide 2 in the rat: effects of dietary fibre
Gut, November 1, 1999; 45(5): 672 - 678.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. P. Boushey, B. Yusta, and D. J. Drucker
Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis
Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E937 - E947.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. G. Munroe, A. K. Gupta, F. Kooshesh, T. B. Vyas, G. Rizkalla, H. Wang, L. Demchyshyn, Z.-J. Yang, R. K. Kamboj, H. Chen, et al.
Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2
PNAS, February 16, 1999; 96(4): 1569 - 1573.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. J. Drucker, B. Yusta, R. P. Boushey, L. DeForest, and P. L. Brubaker
Human [Gly2]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis
Am J Physiol Gastrointest Liver Physiol, January 1, 1999; 276(1): G79 - G91.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Yusta, R. P. Boushey, and D. J. Drucker
The Glucagon-like Peptide-2 Receptor Mediates Direct Inhibition of Cellular Apoptosis via a cAMP-dependent Protein Kinase-independent Pathway
J. Biol. Chem., November 3, 2000; 275(45): 35345 - 35352.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Bjerknes and H. Cheng
Modulation of specific intestinal epithelial progenitors by enteric neurons
PNAS, October 23, 2001; 98(22): 12497 - 12502.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online